Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333

1.

Home-based records and vaccination appointment stickers as parental reminders to reduce vaccination dropout in Indonesia: A cluster-randomized controlled trial.

Wallace AS, Peetosutan K, Untung A, Ricardo M, Yosephine P, Wannemuehler K, Brown DW, McFarland DA, Orenstein WA, Rosenberg ES, Omer SB, Daniels D.

Vaccine. 2019 Oct 23;37(45):6814-6823. doi: 10.1016/j.vaccine.2019.09.040. Epub 2019 Sep 26.

PMID:
31564451
2.

MomsTalkShots: An individually tailored educational application for maternal and infant vaccines.

Salmon DA, Limaye RJ, Dudley MZ, Oloko OK, Church-Balin C, Ellingson MK, Spina CI, Brewer SE, Orenstein WA, Halsey NA, Chamberlain AT, Bednarczyk RA, Malik FA, Frew PM, O'Leary ST, Omer SB.

Vaccine. 2019 Oct 8;37(43):6478-6485. doi: 10.1016/j.vaccine.2019.08.080. Epub 2019 Sep 7.

PMID:
31506192
3.

Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood.

Rasheed MAU, Hickman CJ, McGrew M, Sowers SB, Mercader S, Hopkins A, Grimes V, Yu T, Wrammert J, Mulligan MJ, Bellini WJ, Rota PA, Orenstein WA, Ahmed R, Edupuganti S.

Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19071-19076. doi: 10.1073/pnas.1905570116. Epub 2019 Sep 3.

PMID:
31481612
4.

The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plans.

Daugherty MA, Hinman AR, Cochi SL, Garon JR, Rodewald LE, Nowak G, McKinlay MA, Mast EE, Orenstein WA.

Vaccine. 2019 Aug 14;37(35):4928-4936. doi: 10.1016/j.vaccine.2019.07.042. Epub 2019 Jul 17.

PMID:
31326253
5.

The Salzburg Statement on Vaccination Acceptance.

Ratzan SC, Bloom BR, El-Mohandes A, Fielding J, Gostin LO, Hodge JG, Hotez P, Kurth A, Larson HJ, Nurse J, Omer SB, Orenstein WA, Salmon D, Rabin K.

J Health Commun. 2019;24(5):581-583. doi: 10.1080/10810730.2019.1622611. Epub 2019 Jul 2.

PMID:
31262227
6.

Evolution of Inactivated Poliovirus Vaccine Use for the Endgame and Beyond.

Bandyopadhyay AS, Orenstein WA.

J Infect Dis. 2019 Jun 26. pii: jiz300. doi: 10.1093/infdis/jiz300. [Epub ahead of print] No abstract available.

PMID:
31242297
7.

Measles.

Strebel PM, Orenstein WA.

N Engl J Med. 2019 Jul 25;381(4):349-357. doi: 10.1056/NEJMcp1905181. Epub 2019 Jul 10. Review. No abstract available.

PMID:
31184814
8.

Challenges in estimating influenza vaccine effectiveness.

Ainslie KEC, Haber M, Orenstein WA.

Expert Rev Vaccines. 2019 Jun;18(6):615-628. doi: 10.1080/14760584.2019.1622419. Epub 2019 May 31.

PMID:
31116070
9.

Missed Opportunities for Rotavirus Vaccination.

Sederdahl BK, Orenstein WA, Yi J, Anderson EJ, Bednarczyk RA.

Pediatrics. 2019 May;143(5). pii: e20182498. doi: 10.1542/peds.2018-2498.

PMID:
31023829
10.

Development and acceptability of a video-based vaccine promotion tutorial for obstetric care providers.

Chamberlain AT, Limaye RJ, O'Leary ST, Frew PM, Brewer SE, Spina CI, Ellingson MK, Dudley MZ, Orenstein WA, Donnelly MA, Riley LE, Ault KA, Salmon DA, Omer SB.

Vaccine. 2019 May 1;37(19):2532-2536. doi: 10.1016/j.vaccine.2019.03.005. Epub 2019 Apr 5.

PMID:
30962093
11.

Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.

Ainslie KEC, Haber M, Orenstein WA.

Vaccine. 2019 Mar 28;37(14):1987-1993. doi: 10.1016/j.vaccine.2019.02.036. Epub 2019 Mar 2.

PMID:
30833155
12.

Classification of global measles cases in 2013-17 as due to policy or vaccination failure: a retrospective review of global surveillance data.

Patel MK, Orenstein WA.

Lancet Glob Health. 2019 Mar;7(3):e313-e320. doi: 10.1016/S2214-109X(18)30492-3.

13.

Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation.

Skowronski DM, De Serres G, Orenstein WA.

Clin Infect Dis. 2019 Aug 30;69(6):1084-1085. doi: 10.1093/cid/ciz113. No abstract available.

14.

Vaccine Trials in Schools: We Must Not Ignore Progress.

Hinman AR, Addiss D, Caplan A, Carlson LM, Lavery JV, Orenstein WA.

Am J Public Health. 2019 Feb;109(2):219-220. doi: 10.2105/AJPH.2018.304798. No abstract available.

PMID:
30649954
15.

Development of a valid and reliable scale to assess parents' beliefs and attitudes about childhood vaccines and their association with vaccination uptake and delay in Ghana.

Wallace AS, Wannemuehler K, Bonsu G, Wardle M, Nyaku M, Amponsah-Achiano K, Dadzie JF, Sarpong FO, Orenstein WA, Rosenberg ES, Omer SB.

Vaccine. 2019 Feb 4;37(6):848-856. doi: 10.1016/j.vaccine.2018.12.055. Epub 2019 Jan 11.

16.

Trends in U.S. Community hospitalizations due to herpes zoster: 2001-2015.

Pham MA, Bednarczyk RA, Becker ER, Orenstein WA, Omer SB.

Vaccine. 2019 Feb 4;37(6):882-888. doi: 10.1016/j.vaccine.2018.12.034. Epub 2019 Jan 4.

PMID:
30616954
17.

Licensure, Approval, and Uptake of Vaccines in the United States.

Pickering LK, Orenstein WA.

J Pediatric Infect Dis Soc. 2018 Dec 26;7(suppl_2):S46-S48. doi: 10.1093/jpids/piy122.

PMID:
30590618
18.

Development of a US trust measure to assess and monitor parental confidence in the vaccine system.

Frew PM, Murden R, Mehta CC, Chamberlain AT, Hinman AR, Nowak G, Mendel J, Aikin A, Randall LA, Hargreaves AL, Omer SB, Orenstein WA, Bednarczyk RA.

Vaccine. 2019 Jan 7;37(2):325-332. doi: 10.1016/j.vaccine.2018.09.043. Epub 2018 Nov 30.

PMID:
30503657
19.

Securing the Eradication of All Polioviruses.

Grassly NC, Orenstein WA.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S1-S3. doi: 10.1093/cid/ciy651. No abstract available.

PMID:
30376096
20.

Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses.

Bhaumik SK, Kulkarni RR, Weldon WC, Silveira ELV, Ahmed H, Gunisetty S, Chandele A, Antia R, Verma H, Sutter R, Pallansch MA, Oberste MS, Villinger F, Orenstein W, Murali-Krishna K.

Clin Infect Dis. 2018 Oct 30;67(suppl_1):S66-S77. doi: 10.1093/cid/ciy634.

21.

A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates From Observational Studies.

Ainslie KEC, Shi M, Haber M, Orenstein WA.

Am J Epidemiol. 2019 Feb 1;188(2):451-460. doi: 10.1093/aje/kwy240.

PMID:
30329006
22.

Disparities in Tdap Vaccination and Vaccine Information Needs Among Pregnant Women in the United States.

Kriss JL, Albert AP, Carter VM, Jiles AJ, Liang JL, Mullen J, Rodriguez L, Howards PP, Orenstein WA, Omer SB, Fisher A.

Matern Child Health J. 2019 Feb;23(2):201-211. doi: 10.1007/s10995-018-2633-8.

PMID:
30288661
23.

Strengthening routine immunization through measles-rubella elimination.

Biellik RJ, Orenstein WA.

Vaccine. 2018 Sep 5;36(37):5645-5650. doi: 10.1016/j.vaccine.2018.07.029. Epub 2018 Jul 21.

24.

Assessing population immunity for measles elimination - The promise and peril of serosurveys.

Durrheim DN, Orenstein WA, Schluter WW.

Vaccine. 2018 Jun 27;36(28):4001-4003. doi: 10.1016/j.vaccine.2018.04.036. Epub 2018 May 21. No abstract available.

PMID:
29793892
25.

Protecting the Community Through Child Vaccination.

Anderson EJ, Daugherty MA, Pickering LK, Orenstein WA, Yogev R.

Clin Infect Dis. 2018 Jul 18;67(3):464-471. doi: 10.1093/cid/ciy142.

PMID:
29471452
26.

The National Vaccine Advisory Committee at 30: Impact and opportunity.

Thompson KM, Gellin BG, Hinman AR, Orenstein WA.

Vaccine. 2018 Mar 7;36(11):1330-1344. doi: 10.1016/j.vaccine.2018.01.068. Review.

PMID:
29422369
27.

Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.

Orenstein WA, Cairns L, Hinman A, Nkowane B, Olivé JM, Reingold AL.

Vaccine. 2018 Jan 11;36 Suppl 1:A35-A42. doi: 10.1016/j.vaccine.2017.10.065. Review.

28.

Measles and Rubella Global Strategic Plan 2012-2020 midterm review.

Orenstein WA, Hinman A, Nkowane B, Olive JM, Reingold A.

Vaccine. 2018 Jan 11;36 Suppl 1:A1-A34. doi: 10.1016/j.vaccine.2017.09.026. Review.

29.

A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.

Shi M, An Q, Ainslie KEC, Haber M, Orenstein WA.

BMC Infect Dis. 2017 Dec 8;17(1):757. doi: 10.1186/s12879-017-2838-2.

30.

Rubella Vaccine-A Tale of Appropriate Caution and Remarkable Success.

Zimmerman LA, Reef SE, Orenstein WA.

JAMA Pediatr. 2018 Jan 1;172(1):95-96. doi: 10.1001/jamapediatrics.2017.4178. No abstract available.

31.

On the bias of estimates of influenza vaccine effectiveness from test-negative studies.

Ainslie KEC, Shi M, Haber M, Orenstein WA.

Vaccine. 2017 Dec 19;35(52):7297-7301. doi: 10.1016/j.vaccine.2017.10.107. Epub 2017 Nov 13.

32.

Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach.

Goodson JL, Alexander JP, Linkins RW, Orenstein WA.

Expert Rev Vaccines. 2017 Dec;16(12):1203-1216. doi: 10.1080/14760584.2017.1393337. Epub 2017 Oct 23. Review.

33.

Vaccine exemptions and the kindergarten vaccination coverage gap.

Smith PJ, Shaw J, Seither R, Lopez A, Hill HA, Underwood M, Knighton C, Zhao Z, Ravanam MS, Greby S, Orenstein WA.

Vaccine. 2017 Sep 25;35(40):5346-5351. doi: 10.1016/j.vaccine.2017.08.036. Epub 2017 Aug 24.

PMID:
28844635
34.

Using Disease Epidemiology to Optimize Immunization Schedules.

Weinbaum CM, Orenstein WA.

JAMA Pediatr. 2017 Oct 1;171(10):944-945. doi: 10.1001/jamapediatrics.2017.2375. No abstract available.

PMID:
28806456
35.

Collaborating to achieve Global Vaccine Action Plan goals.

Hinman AR, Orenstein WA.

Lancet. 2017 Jul 29;390(10093):451-452. doi: 10.1016/S0140-6736(17)31370-3. Epub 2017 Jul 27. No abstract available.

PMID:
28792404
36.

FDA licensure of and ACIP recommendations for vaccines.

Pickering LK, Orenstein WA, Sun W, Baker CJ.

Vaccine. 2017 Sep 5;35(37):5027-5036. doi: 10.1016/j.vaccine.2017.07.023. Epub 2017 Jul 29.

PMID:
28765004
37.

The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan - 2011-2013.

Cowger TL, Burns CC, Sharif S, Gary HE Jr, Iber J, Henderson E, Malik F, Zahoor Zaidi SS, Shaukat S, Rehman L, Pallansch MA, Orenstein WA.

PLoS One. 2017 Jul 25;12(7):e0180608. doi: 10.1371/journal.pone.0180608. eCollection 2017.

38.

High population immunity reduces poliovirus community transmission.

Garon J, Sutter RW, Orenstein W.

Lancet Infect Dis. 2017 Oct;17(10):1009-1011. doi: 10.1016/S1473-3099(17)30417-6. Epub 2017 Jul 7. No abstract available.

39.

Achieving an Optimal Childhood Vaccine Policy.

Opel DJ, Schwartz JL, Omer SB, Silverman R, Duchin J, Kodish E, Diekema DS, Marcuse EK, Orenstein W.

JAMA Pediatr. 2017 Sep 1;171(9):893-896. doi: 10.1001/jamapediatrics.2017.1868.

PMID:
28672396
40.

Simply put: Vaccination saves lives.

Orenstein WA, Ahmed R.

Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4031-4033. doi: 10.1073/pnas.1704507114. Epub 2017 Apr 10. No abstract available.

41.

Policy making for vaccine use as a driver of vaccine innovation and development in the developed world.

Seib K, Pollard AJ, de Wals P, Andrews RM, Zhou F, Hatchett RJ, Pickering LK, Orenstein WA.

Vaccine. 2017 Mar 7;35(10):1380-1389. doi: 10.1016/j.vaccine.2016.10.080. Review.

PMID:
28253995
42.

Evaluation of two vaccine education interventions to improve pertussis vaccination among pregnant African American women: A randomized controlled trial.

Kriss JL, Frew PM, Cortes M, Malik FA, Chamberlain AT, Seib K, Flowers L, Ault KA, Howards PP, Orenstein WA, Omer SB.

Vaccine. 2017 Mar 13;35(11):1551-1558. doi: 10.1016/j.vaccine.2017.01.037. Epub 2017 Feb 16.

43.

DA Henderson-physically gone but his impact will live on forever.

Orenstein WA.

Ann Epidemiol. 2017 Mar;27(3):155-156. doi: 10.1016/j.annepidem.2017.01.003. Epub 2017 Jan 17. No abstract available.

PMID:
28160972
44.

How to improve influenza vaccine coverage of healthcare personnel.

Weber DJ, Orenstein W, Rutala WA.

Isr J Health Policy Res. 2016 Dec 16;5:61. doi: 10.1186/s13584-016-0122-3. eCollection 2016.

45.

New poliovirus vaccine schedules - Authors' reply.

Asturias EJ, Bandyopadhyay AS, Clemens R, Orenstein W, Rüttimann R.

Lancet. 2016 Nov 19;388(10059):2478. doi: 10.1016/S0140-6736(16)31717-2. No abstract available.

PMID:
27871743
46.

Epidemiology of Pertussis Among Young Pakistani Infants: A Community-Based Prospective Surveillance Study.

Omer SB, Kazi AM, Bednarczyk RA, Allen KE, Quinn CP, Aziz F, Sial K, Phadke VK, Tondella ML, Williams MM, Orenstein WA, Ali SA.

Clin Infect Dis. 2016 Dec 1;63(suppl 4):S148-S153.

47.

The Need and Potential of Inactivated Poliovirus Vaccine.

Garon J, Orenstein W, John TJ.

Indian Pediatr. 2016 Aug 7;53 Suppl 1:S2-S6.

PMID:
27771632
48.

Changes in childhood immunization decisions in the United States: Results from 2012 & 2014 National Parental Surveys.

Frew PM, Fisher AK, Basket MM, Chung Y, Schamel J, Weiner JL, Mullen J, Omer SB, Orenstein WA.

Vaccine. 2016 Nov 4;34(46):5689-5696. doi: 10.1016/j.vaccine.2016.08.001. Epub 2016 Oct 6.

49.

Improving the Science of Measles Prevention-Will It Make for a Better Immunization Program?

Garon J, Orenstein W.

PLoS Med. 2016 Oct 11;13(10):e1002145. doi: 10.1371/journal.pmed.1002145. eCollection 2016 Oct.

50.

Estimating the Number of Measles-Susceptible Children and Adolescents in the United States Using Data From the National Immunization Survey-Teen (NIS-Teen).

Bednarczyk RA, Orenstein WA, Omer SB.

Am J Epidemiol. 2016 Jul 15;184(2):148-56. doi: 10.1093/aje/kwv320. Epub 2016 Jun 23.

PMID:
27338281

Supplemental Content

Loading ...
Support Center